Medical Condition News

RSS

Insulin has met an evolutionary cul-de-sac making most people vulnerable to Type 2 diabetes

Scientists have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to Type 2 diabetes.

5 Nov 2020

COVID-19 patients who experience strokes appear to have worse outcomes

People who experience strokes while infected with COVID-19 appear to be left with greater disability after the stroke, according a study led by UCL and UCLH researchers.

5 Nov 2020

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

There are times when adding something new to the mix makes it better. Give Popeye some spinach, and you've got a fighting machine. Give Mario a mushroom, and he becomes invincible. Without drinking a potion, Alice in Wonderland would never fit through the door.

5 Nov 2020

HKUST researchers identify new therapeutic targets for Alzheimer's disease

Researchers at the Hong Kong University of Science and Technology have identified new therapeutic targets for Alzheimer's disease (AD) by studying the patients' brain with a newly-developed methodology.

5 Nov 2020

NIH awards grant totaling $19.5M for Down syndrome research project

Scientists and data experts are joining forces to create the world's first centralized platform for Down syndrome researchers to share, access, and analyze data.

5 Nov 2020

Climate change linked to higher rates of cancer

Climate change will bring an acute toll worldwide, with rising temperatures, wildfires and poor air quality, accompanied by higher rates of cancer, especially lung, skin and gastrointestinal cancers, according to a new report from UC San Francisco.

5 Nov 2020

Medicaid expansion associated with decreased cancer mortality rates

In states that have expanded Medicaid availability as part of the Affordable Care Act (ACA), mortality rates for three major forms of cancer are significantly lower than in states that have not expanded their Medicaid, a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard University shows.

5 Nov 2020

Study explains the global burden of disability from musculoskeletal conditions

Musculoskeletal disorders--which affect muscles, tendons, ligaments, bones, and joints--can severely affect individuals' physical and mental health, and they're especially prevalent among aging adults.

5 Nov 2020

Providing the best psychiatric care within a safe environment during COVID-19 pandemic

The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks.

4 Nov 2020

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about 8 days, but there is a wide range of variability from person to person.

4 Nov 2020

Researchers identify a genetic basis for ANCA-associated vasculitis

Autoimmune disease is fundamentally a mystery: whyever should an organism systematically set out to harm itself?

4 Nov 2020

People treated with statins have 22% to 25% lower risk of dying from COVID-19

Coronavirus has infected more than 40 million people around the world and has caused more than a million deaths in less than a year.

4 Nov 2020

UH professor is developing a Chinese herbal medicine formula to improve cancer therapy

University of Houston professor of pharmaceutics Ming Hu is developing and testing an ancient Chinese herbal medicine formula, first described in 280 A.D., to improve cancer therapy.

4 Nov 2020

Researchers develop novel therapeutic approach against COPD

Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

4 Nov 2020

Psilocybin may be effective in patients suffering from major depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.

4 Nov 2020

Medical Condition News

Insulin has met an evolutionary cul-de-sac making most people vulnerable to Type 2 diabetes

COVID-19 patients who experience strokes appear to have worse outcomes

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

HKUST researchers identify new therapeutic targets for Alzheimer's disease

NIH awards grant totaling $19.5M for Down syndrome research project

Climate change linked to higher rates of cancer

Medicaid expansion associated with decreased cancer mortality rates

Study explains the global burden of disability from musculoskeletal conditions

Providing the best psychiatric care within a safe environment during COVID-19 pandemic

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

Researchers identify a genetic basis for ANCA-associated vasculitis

People treated with statins have 22% to 25% lower risk of dying from COVID-19

UH professor is developing a Chinese herbal medicine formula to improve cancer therapy

Researchers develop novel therapeutic approach against COPD

Psilocybin may be effective in patients suffering from major depression

Extreme levels of serum uric acid linked to substantial reduction in patient survival

Genetic mutation may accelerate heart function decline in DMD patients

Experts release new guidance for endoscopists on how to assess colorectal lesions

Low dose computed tomography shows potential for opportunistic screening of osteoporosis

Dietary supplement helps prevent fatty liver disease in rats

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News